Patrice Carde

8.7k citations

152 papers · 4.3k indexed · h-index 39

Pathology and Forensic Medicine top 0.2%
- Lymphoma Diagnosis and Treatment 95
Genetics top 1%
- Chronic Lymphocytic Leukemia Research 30
Neurology top 1%
- CNS Lymphoma Diagnosis and Treatment 19
Oncology top 2%
- Viral-associated cancers and disorders 31
- Cancer Treatment and Pharmacology 10
- Lung Cancer Research Studies 8
Pulmonary and Respiratory Medicine top 1%
- Lung Cancer Treatments and Mutations 47
Molecular Biology
- DNA Repair Mechanisms 9

Co-authors: M. Henry‐Amar José Thomas M. Hayat M Tubiana Jean‐Marc Cosset Evert M. Noordijk E.M. Noordijk M. Monconduit
Cited by: Pathology and Forensic Medicine Genetics Neurology
Partner nations: France Netherlands Belgium

In The Last Decade

Patrice Carde

151 papers receiving 4.1k citations

Peers

Countries citing papers authored by Patrice Carde

Since Specialization

Citations

This map shows the geographic impact of Patrice Carde's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patrice Carde with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patrice Carde more than expected).

Fields of papers citing papers by Patrice Carde

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Patrice Carde. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patrice Carde. The network helps show where Patrice Carde may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Patrice Carde, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Patrice Carde Line = papers co-authored together Patrice Carde links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Angioimmunoblastic T‐cell lymphoma and Kaposi sarcoma: A fortuitous collision? Elsa Poullot,Dina Milowich,François Lemonnier,Bettina Bisig,Cyrielle Robe,Laura Pelletier,Audrey Letourneau,Aurélie Dupuy,Nouhoum Sako,Nicolas Ketterer,Patrice Carde,Peggy Dartigues,Marie‐Hélène Delfau‐Larue,Laurence de Leval,Philippe Gaulard	2023	1
2	High Resolution and Automatable Cytogenetic Biodosimetry Using In Situ Telomere and Centromere Hybridization for the Accurate Detection of DNA Damage: An Overview Radhia M’kacher,Bruno Colicchio,Steffen Junker,Elie Maalouf,Leonhard Heidingsfelder,Andreas Plesch,Alain Dieterlen,Éric Jeandidier,Patrice Carde,Philippe Voisin	2023	8
3	Le lymphome de Hodgkin : stratégies thérapeutiques actuelles et futures Anthony Turpin,Jean‐Marie Michot,Emmanuelle Kempf,R. Mazeron,Peggy Dartigues,M. Terroir,A. Boros,Serge Bonnetier,Cristina Castilla‐Llorente,Téreza Coman,Alina Danu,David Ghez,Sylvain Pilorge,Julia Arfi‐Rouche,Laurent Dercle,Jean‐Charles Soria,Patrice Carde,Vincent Ribrag,Christophe Fermé,Julien Lazarovici	2017	3
4	ABVD (8 cycles) versus BEACOPP (4 escalated cycles ≥4 baseline): final results in stage III–IV low-risk Hodgkin lymphoma (IPS 0–2) of the LYSA H34 randomized trial Nicolas Mounier,Pauline Brice,Serge Bologna,Josette Brière,Isabelle Gaillard,Marian Heczko,Jean Gabarre,Olivier Casasnovas,J. Jaubert,Philippe Colin,Alain Delmer,A. Devidas,Emmanuel Bachy,Emmanuelle Nicolas‐Virelizier,A. Aoudjhane,Catherine Humbrecht,Marc André,Patrice Carde	2014	66
5	Sperm quality before treatment in patients with early stage Hodgkin's lymphoma enrolled in EORTC-GELA Lymphoma Group trials Marleen A. E. van der Kaaij,Natacha Heutte,Jannie van Echten‐Arends,John Raemaekers,Patrice Carde,E.M. Noordijk,C. Fermé,José Thomas,Houchingue Eghbali,Pauline Brice,Caroline Bonmati,M. Henry‐Amar,Hanneke C. Kluin‐Nelemans	2009	49
6	JC human polyomavirus is associated to chromosomal instability in peripheral blood lymphocytes of Hodgkin’s lymphoma patients and poor clinical outcome Radhia M’Kacher,Laurent Andréoletti,Stéphane Flamant,Fabien Milliat,T. Girinsky,Joseph Dossou,D. Violot,Elias Assaf,Bernard Clausse,Serge Koscielny,Jean Bourhis,J. Bosq,Alain Bernheim,C Parmentier,Patrice Carde	2009	21
7	Combined-Modality Therapy for Clinical Stage I or II Hodgkin's Lymphoma: Long-Term Results of the European Organisation for Research and Treatment of Cancer H7 Randomized Controlled Trials Evert M. Noordijk,Patrice Carde,N. Dupouy,Anton Hagenbeek,Augustinus D. G. Krol,Hanneke C. Kluin‐Nelemans,Umberto Tirelli,M. Monconduit,José Thomas,Houchingue Eghbali,Berthe M.P. Aleman,Jacques Bosq,Marjeta Vovk,Tom Verschueren,Anne-Marie Pény,T. Girinsky,John Raemaekers,M. Henry‐Amar	2006	149
8	Prognostic value of the age-adjusted International Prognostic Index in chemosensitive recurrent or refractory non-Hodgkin's lymphomas treated with high-dose BEAM therapy and autologous stem cell transplantation Elias Jabbour,N Peslin,P Arnaud,Christophe Fermé,Patrice Carde,JM Vantelon,Catherine Bocaccio,JH Bourhis,Serge Koscielny,Vincent Ribrag	2005	10
9	Le cancer en 2004 Maurice Tubiana,Patrice Carde	2004	1
10	Outcome of Elderly Patients with Aggressive Non-Hodgkin's Lymphoma Refractory to or Relapsing after First-line CHOP or CHOP-like Chemotherapy: A Low Probability of Cure Elias Jabbour,B Chalhoub,Florence Suzan,Samir Aloulou,Călin Cainap,N. Toumi,Christophe Fermé,Patrice Carde,Vincent Ribrag	2004	15
11	Involved field irradiation (IFRT) does not improve outcome in patients with stage III/IV Hodgkin's lymphoma (HL) in complete remission after MOPP/ABV (M/A): Results of the randomised EORTC trial 20884 Jmm Raemaekers,Berthe M.P. Aleman,M. Henry‐Amar,Umberto Tirelli,Anton Hagenbeek,Patrice Carde,W Peters,Radka Tomšič,A Van Hoof,M. van ‘t Veer,José Thomas,W Schroyens,Hanneke C. Kluin‐Nelemans,Catherine Sebban,Dominique Bron,Houchingue Eghbali,A. Pinna,Mandard Am	2001	6
12	A high and sustained response rate in refractory or relapsing low-grade lymphoma masses after low-dose radiation: analysis of predictive parameters of response to treatment T. Girinsky,Dolores Guillot-Vals,Serge Koscielny,Jean-Marc Cosset,G. Ganem,Patrice Carde,Monique Monhonval,Renata Junqueira Pereira,Jacques Bosq,Vincent Ribrag,J Vantelon,Jean‐Nicolas Munck	2001	52
13	The EORTC trials for limited stage Hodgkin's disease Jean‐Marc Cosset,M. Henry‐Amar,J.H. Meerwaldt,Patrice Carde,Evert M. Noordijk,José Thomas,J. M. V. Burgers,R. Somers,M. Hayat,M Tubiana	1992	47
14	Immunoscintigraphy in Hodgkin's disease and anaphastic large cell lymphomas: Results in 18 patients using the iodine radiolabeled monoclonal antibody HRS-3 L. Da Costa,Patrice Carde,J Lumbroso,M. Ricard,Michael Pfreundschuh,J. Bosq,L. Manil,Volker Diehl,C Parmentier	1992	20
15	Radiotherapy versus combined modality in early stages Lena Specht,Patrice Carde,Peter Mauch,Stefano Maria Magrini,María Teresa Santarelli	1992	28
16	Hodgkin's disease--I: Identification and classification. Patrice Carde	1992	1
17	Therapeutic implications and sites of relapse predicted by elevated posttherapy erythrocyte sedimentation rate in early stage Hodgkin disease Samuel Friedman,M. Henry‐Amar,Jean‐Marc Cosset,Patrice Carde,Marcel Hayat,N. Dupouy,Maurice Tubiana	1991	5
18	[Papulovesicular eruption of the face in chronic lymphoid leukemia]. Desvignes,J. Bosq,Guillaume Jc,P Charpentier,Patrice Carde,C Jasmin,Avril Mf	1990	1
19	Prognostic factors in non-Hodgkin's lymphoma M Tubiana,Patrice Carde,J. M. V. Burgers,Jean‐Marc Cosset,M. van Glabbeke,R. Somers	1986	19
20	Chimiothérapie première dans les sarcomes des parties molles considérés comme inopérables. Jacques Rouëssé,T. Le Chevalier,G Contesso,D Sarrazin,Jeanne Amiel,Dieter Sevin,Patrice Carde,J Génin	1983	3

About Patrice Carde

Patrice Carde is a scholar working on Pathology and Forensic Medicine, Genetics and Oncology, having authored 152 papers that have together received 4.3k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (95 papers), Lung Cancer Treatments and Mutations (47 papers), Viral-associated cancers and disorders (31 papers), Chronic Lymphocytic Leukemia Research (30 papers), CNS Lymphoma Diagnosis and Treatment (19 papers), Cancer Treatment and Pharmacology (10 papers), DNA Repair Mechanisms (9 papers) and Lung Cancer Research Studies (8 papers). The work is most often cited by research in Pathology and Forensic Medicine (2.8k citations), Genetics (706 citations) and Neurology (877 citations). Patrice Carde has collaborated with scholars based in France, Netherlands and Belgium. Frequent co-authors include M. Henry‐Amar, José Thomas, M. Hayat, M Tubiana, Jean‐Marc Cosset, Evert M. Noordijk, E.M. Noordijk, M. Monconduit, Françoise Laval and A Tanguy.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact